Life Science Company News

Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

4Front Ventures to Report Second Quarter 2021 Financial Results on August 16, 2021

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

MindMics Announces Results from a Clinical Trial of Revolutionary Earbuds Technology -- In-ear Infrasonic Hemodynography - to Achieve Cardiac Arrhythmia Assessment beyond that of ECG

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

FDA Agrees with Galmed's Plan to use Aramchol Meglumine in the Randomized Double-Blind Placebo-Controlled Part of the Phase 3 ARMOR study

- FDA agreed that Galmed can proceed with its proposed clinical studies with Aramchol meglumine in lieu of Aramchol free acid without the need to repeat nonclinical and clinical studies.;- FDA supported Galmed's limited clinical pharmacology study plan with respect to Aramchol meglumine.;- Based... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Armata Pharmaceuticals Announces Chief Executive Officer Transition

Todd R. Patrick to retire; Board of Directors appoints Brian Varnum, Ph.D., current President and Chief Development Officer, as new Chief Executive Officer;Mr. Patrick to remain with Armata Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca's anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced at a Premium to Market

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Delix Therapeutics Continues Rapid Growth with Appointment of Chief Medical Officer

Industry veteran, CNS clinical development expert Dr. Brigitte Robertson joins neuroscience company Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

FDA Clears Vaxart's IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate

Vaccine candidate expressing S-only protein produced higher serum antibodies than construct expressing both S and N in NHP study;Phase II clinical trial with S-only candidate to begin in 2H21;Development of this and other S-only constructs will proceed in parallel with that of S+N construct, as... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Avidity Biosciences Receives IND Clearance from FDA to Proceed with the Phase 1/2 MARINA™ Trial of AOC 1001 in Adults with Myotonic Dystrophy (DM1)

-First antibody oligonucleotide conjugate (AOC™) to enter the clinic-;-Volume 2 of virtual investor and analyst series today at 8:30 am ET featuring Dr. Nicholas E. Johnson, an expert and leading physician treating DM1 - Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Maryland Based Children's HealthCare Organization Refreshes Online Identity & Launches New Website

The Child & Teen Wellness Center (CTWC), a Maryland based children's healthcare and wellness organization, announced today a brand refresh. Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Reproductive Care Center Welcomes Reproductive Endocrinologist Kristi Maas, MD to Utah Fertility Team

The addition of Dr. Maas is the latest strategic move for Reproductive Care Center, who last week announced its new partnership with the Boston IVF fertility network. Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Memorial Sloan Kettering Cancer Center Launches MSKCC India to Expand Access to World-Renowned Oncologists, Cancer Care, Research, and Education

First-of-its-kind initiative provides patients in India with access to remote opinions and consultations, using technology from India-based telemedicine provider iCliniq;Physical location in Chennai, India will serve as a telemedicine hub to coordinate with Memorial Sloan Kettering Cancer Center... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Health Holland Awards Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals

-Health Holland has awarded a grant of approximately $500,000 USD to Leiden University Medical Center to further study the mechanism of action of pol IIIC inhibitors in scientific collaboration with Acurx Pharmaceuticals;-Innovative research will study 3-dimensional structures of DNA polymerases... Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Allegheny Health Network Physicians Initiate Groundbreaking Clinical Trial Exploring Use of Deep Brain Stimulation to Treat Obesity

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

DisposeRx Direct, LLC Launches Online Store for Medication Disposal Packets

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Micronoma Wins Bio-IT World Innovative Practices Award

Machine learning and microbiome-driven liquid biopsy technology draws recognition for improving early cancer diagnosis and chances of survival Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

Hoth Therapeutics Initiates Preclinical Study of HT-ALZ for Alzheimer's Disease

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

PharmaVOICE Magazine Announces the 2021 PharmaVOICE 100 and Red Jacket Award Honorees

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

IZI Medical Products Announces the Launch of Vertefix® HV Cement with Insite™ Tracking Beads

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021

RealView Imaging Ltd., World Leader in Medical Holography, Receives FDA Clearance for its Groundbreaking HOLOSCOPE™-i Holographic System

Read more ››
By: PR Newswire Association LLC. - 02 Aug 2021
Results 81 - 100 out of 500 displayed.
«  1  2  3  4 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate